Pfizer sues Novo Nordisk, Metsera for breach of merger agreement
Pfizer said Friday it’s suing Novo Nordisk and obesity biotech Metsera, a day after Novo set off a bidding war against Pfizer to acquire Metsera. A month ago, Pfizer said that it would acquire Metsera for $4.9 billion. But Novo on Thursday launched a takeover bid valuing the biotech at around $6 billion, triggering a … [Read more…]